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background:  STEMI and age are both risk factors for developing atrial fibrillation (AF) and thromboembolic complications. However, incidence of 
AF among elderly patients (pts) undergoing primary PCI (P-PCI) has been scarcely evaluated. Our aim was to assess the association between older 
age and risk of new-onset AF (NOAF) in consecutive pts admitted for P-PCI.
methods:  We conducted a prospective study in a tertiary care hospital. Study population comprised all pts with suspected STEMI admitted for 
P-PCI. Pts were divided into age groups: <75 years and ≥75 years. Clinical end point was the incidence of NOAF, defined as any episode of AF lasting 
>30 seconds, newly discovered at admission or during hospitalization.
results:  462 patients were included, 119 (25.8%) of whom were ≥75 years old. Overall the rate of NOAF was 13.9%. Baseline characteristics are 
shown in table. Elderly pts showed a particular risk profile, with high prevalence of arterial hypertension, chronic kidney disease and multivessel 
disease. These pts presented with longer delays and had more complicated hospital course. Older group had an incidence of NOAF nearly 3 times 
higher than younger group (RR 2.88 (95% CI, 1.85-4.49), p<0.001). In multivariate analysis, older age and Killip class were independent predictors 
of NOAF.
conclusions:  NOAF occurs in about one-third of elderly patients undergoing primary PCI. This high rate must be taken into account when selecting 
the type of stent and antithrombotic therapy.
<75 years (n=343) ≥75 years (n=119) p-value
Gender (male) 78% (269) 59% (70) <0.001
BMI 27 (24-29) 27 (24-29) 0.935
Hypertension 46% (150) 75% (89) <0.001
Diabetes 17% (59) 20% (24) 0.468
Dyslipidemia 47% (162) 31% (37) 0.002
Smoker 66% (224) 22% (25) <0.001
Chronic kidney disease 5% (18) 18% (21) <0.001
Prior CAD 11% (37) 11% (13) 0.967
Anterior location 33% (113) 36% (43) 0.526
Symptoms duration (min) 120 (70-192) 177 (110-299) <0.001
Multi vessel disease 41% (140) 59% (70) 0.001
LVEF at presentation 60 (51-70) 54 (44-60) <0.001
Maximum Killip class III-IV 11% (36) 26% (31) <0.001
Peak CK 1903 (910-3199) 1820 (1071-3118) 0.874
NOAF 9% (32) 27% (32) <0.001
